These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17108211)

  • 41. Characterization of circulating DNA in healthy human plasma.
    Suzuki N; Kamataki A; Yamaki J; Homma Y
    Clin Chim Acta; 2008 Jan; 387(1-2):55-8. PubMed ID: 17916343
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serial assessment of human tumor burdens in mice by the analysis of circulating DNA.
    Rago C; Huso DL; Diehl F; Karim B; Liu G; Papadopoulos N; Samuels Y; Velculescu VE; Vogelstein B; Kinzler KW; Diaz LA
    Cancer Res; 2007 Oct; 67(19):9364-70. PubMed ID: 17909045
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sensitive detection of plasma/serum DNA in patients with systemic lupus erythematosus.
    Chen JA; Meister S; Urbonaviciute V; Rödel F; Wilhelm S; Kalden JR; Manger K; Voll RE
    Autoimmunity; 2007 Jun; 40(4):307-10. PubMed ID: 17516216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated levels of circulating cell-free DNA in the blood of patients with hepatitis C virus-associated hepatocellular carcinoma.
    Iizuka N; Sakaida I; Moribe T; Fujita N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Uchida K; Terai S; Sakamoto K; Tamesa T; Oka M
    Anticancer Res; 2006; 26(6C):4713-9. PubMed ID: 17214331
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantification of LINE1 in circulating DNA as a molecular biomarker of breast cancer.
    Sunami E; Vu AT; Nguyen SL; Giuliano AE; Hoon DS
    Ann N Y Acad Sci; 2008 Aug; 1137():171-4. PubMed ID: 18837943
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantification of total plasma cell-free DNA in ovarian cancer using real-time PCR.
    Kamat AA; Sood AK; Dang D; Gershenson DM; Simpson JL; Bischoff FZ
    Ann N Y Acad Sci; 2006 Sep; 1075():230-4. PubMed ID: 17108216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantification of circulating plasma DNA fragments as tumor markers in patients with esophageal cancer.
    Tomita H; Ichikawa D; Ikoma D; Sai S; Tani N; Ikoma H; Fujiwara H; Kikuchi S; Okamoto K; Ochiai T; Otsuji E
    Anticancer Res; 2007; 27(4C):2737-41. PubMed ID: 17695440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Relationships between thiopurine methyltransferase gene polymorphisms and its enzymatic activity].
    Ma XL; Wu MY; Hu YM; Zu P; Li ZG
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):456-9. PubMed ID: 17152495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating cell-free DNA is elevated in postmenopausal compared with pre- and perimenopausal women.
    Fisher T; Powell E; Yuwono NL; Ford CE; Warton K
    Menopause; 2024 Mar; 31(3):171-175. PubMed ID: 38385729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Persistent aberrations in circulating DNA integrity after radiotherapy are associated with poor prognosis in nasopharyngeal carcinoma patients.
    Chan KC; Leung SF; Yeung SW; Chan AT; Lo YM
    Clin Cancer Res; 2008 Jul; 14(13):4141-5. PubMed ID: 18593992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
    Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
    Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of fluorescence-based methods for total vs. amplifiable DNA quantification in plasma of lung cancer patients.
    Szpechcinski A; Struniawska R; Zaleska J; Chabowski M; Orlowski T; Roszkowski K; Chorostowska-Wynimko J
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():675-81. PubMed ID: 19218694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors.
    Zachariah RR; Schmid S; Buerki N; Radpour R; Holzgreve W; Zhong X
    Obstet Gynecol; 2008 Oct; 112(4):843-50. PubMed ID: 18827127
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimization of an RNA isolation procedure from plasma samples.
    Cerkovnik P; Perhavec A; Zgajnar J; Novakovic S
    Int J Mol Med; 2007 Sep; 20(3):293-300. PubMed ID: 17671732
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Origins, structures, and functions of circulating DNA in oncology.
    Thierry AR; El Messaoudi S; Gahan PB; Anker P; Stroun M
    Cancer Metastasis Rev; 2016 Sep; 35(3):347-76. PubMed ID: 27392603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of methylated circulating DNA in cancer patients' blood.
    Sunami E; Vu AT; Nguyen SL; Hoon DS
    Methods Mol Biol; 2009; 507():349-56. PubMed ID: 18987826
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative analysis of cell-free Epstein-Barr virus DNA in the plasma of patients with peripheral T-cell and NK-cell lymphomas and peripheral T-cell proliferative diseases.
    Suwiwat S; Pradutkanchana J; Ishida T; Mitarnun W
    J Clin Virol; 2007 Dec; 40(4):277-83. PubMed ID: 17996493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunization of rabbits with DNase I produces polyclonal antibodies with DNase and RNase activities.
    Krasnorutskii MA; Buneva VN; Nevinsky GA
    J Mol Recognit; 2008; 21(4):233-42. PubMed ID: 18446884
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protease Activity and Cell-Free DNA in Blood Plasma of Healthy Donors and Breast Cancer Patients.
    Tamkovich S; Bryzgunova O
    J Immunoassay Immunochem; 2016; 37(2):141-53. PubMed ID: 26264080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.